Genetic Technologies (Genetic Technologies) EV-to-EBITDA : (As of Apr. 25, 2024)

Genetic Technologies EV-to-EBITDA Chart

Genetic Technologies Annual Data
	Trend	Jun14	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23
EV-to-EBITDA		Get a 7-Day Free Trial					-2.42	-4.00	-8.38	-2.53	-1.92

Genetic Technologies Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															-	-	-1.92	-	-

Competitive Comparison of Genetic Technologies's EV-to-EBITDA

For the Diagnostics & Research subindustry, Genetic Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Technologies's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Genetic Technologies's EV-to-EBITDA falls into.

Genetic Technologies EV-to-EBITDA Calculation

Genetic Technologies's EV-to-EBITDA for today is calculated as:

Genetic Technologies's current Enterprise Value is $7.17 Mil.
Genetic Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Technologies  (NAS:GENE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Genetic Technologies's PE Ratio for today is calculated as:

Genetic Technologies's share price for today is $2.18.
Genetic Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.249.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Genetic Technologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies (Genetic Technologies) Business Description